Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Clinical Chemistry and Laboratory Medicine
|
August 2, 2012
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Thomas Strecker, Jennifer Uhlendorff, Sandra Diederich, et al.
Plos Pathogens
|
January 26, 2013
Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research
Carla Nisii, Concetta Castilletti, Hervé Raoul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 21, 2015
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
Thomas Strecker, Bernadett Palyi, Heinz Ellerbrok, et al.
Nature Biotechnology
|
September 11, 2009
Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray
Robert A Childs, Angelina S Palma, Steve Wharton, et al.
Vaccines
|
April 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
Alexandra Kupke, Asisa Volz, Erik Dietzel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 19, 2025
Comparative evaluation of a multiplex polymerase chain reaction panel for high-consequence infectious diseases against conventional diagnostics in travelers with febrile diseases
Frauke Borgans, Sebastian Metz, Tobias Appel, et al.
Emerging Infectious Diseases
|
November 7, 2009
European perspective of 2-person rule for biosafety level 4 laboratories
Giuseppe Ippolito, Carla Nisii, Antonino Di Caro, et al.
Journal of Immunological Methods
|
January 7, 2021
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies
Verena Krähling, Sandro Halwe, Cornelius Rohde, et al.
Cell Reports
|
August 31, 2017
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
Anne Rechtien, Laura Richert, Hadrien Lorenzo, et al.
Science (New York, N.Y.)
|
December 4, 2003
Phylogeny of the SARS coronavirus
Markus Eickmann, Stephan Becker, Hans-Dieter Klenk, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Clinical Chemistry and Laboratory Medicine
|
August 2, 2012
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Thomas Strecker, Jennifer Uhlendorff, Sandra Diederich, et al.
Plos Pathogens
|
January 26, 2013
Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research
Carla Nisii, Concetta Castilletti, Hervé Raoul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 21, 2015
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
Thomas Strecker, Bernadett Palyi, Heinz Ellerbrok, et al.
Nature Biotechnology
|
September 11, 2009
Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray
Robert A Childs, Angelina S Palma, Steve Wharton, et al.
Vaccines
|
April 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
Alexandra Kupke, Asisa Volz, Erik Dietzel, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 19, 2025
Comparative evaluation of a multiplex polymerase chain reaction panel for high-consequence infectious diseases against conventional diagnostics in travelers with febrile diseases
Frauke Borgans, Sebastian Metz, Tobias Appel, et al.
Emerging Infectious Diseases
|
November 7, 2009
European perspective of 2-person rule for biosafety level 4 laboratories
Giuseppe Ippolito, Carla Nisii, Antonino Di Caro, et al.
Journal of Immunological Methods
|
January 7, 2021
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies
Verena Krähling, Sandro Halwe, Cornelius Rohde, et al.
Cell Reports
|
August 31, 2017
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
Anne Rechtien, Laura Richert, Hadrien Lorenzo, et al.
Science (New York, N.Y.)
|
December 4, 2003
Phylogeny of the SARS coronavirus
Markus Eickmann, Stephan Becker, Hans-Dieter Klenk, et al.
Page
of 8